Skip to main content
Addgene

f1H (264)
(Plasmid #24425)

Full plasmid sequence is not available for this item.

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 24425 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pSecTag2
  • Backbone manufacturer
    Invitrogen
  • Backbone size w/o insert (bp) 5100
  • Vector type
    Mammalian Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    SULF1
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    2600
  • Mutation
    22aa N-terminal truncation
  • Entrez Gene
    SULF1 (a.k.a. SULF-1)
  • Tags / Fusion Proteins
    • FLAG (N terminal on insert)
    • Myc (C terminal on insert)
    • His (C terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site BamHI (unknown if destroyed)
  • 3′ cloning site XhoI (unknown if destroyed)
  • 5′ sequencing primer CMV-F, T7
  • 3′ sequencing primer BGH-rev
  • (Common Sequencing Primers)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    f1H (264) was a gift from Steven Rosen (Addgene plasmid # 24425 ; http://n2t.net/addgene:24425 ; RRID:Addgene_24425)
  • For your References section:

    Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer. Morimoto-Tomita M, Uchimura K, Bistrup A, Lum DH, Egeblad M, Boudreau N, Werb Z, Rosen SD. Neoplasia. 2005 Nov . 7(11):1001-10. 10.1593/neo.05496 PubMed 16331886